Nant Capital, LLC is 10% at ImmunityBio, Inc. (IBRX). They have made 1 open-market trade across 1 company since 2021, most recently 2024-11-15.
CIK 0001675758
1 open-market purchase totalling $2K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HLGN | BUY | 2023-04-13 | 2023-04-17 | $0.25 | $2K | -18.5% | -15.5% | -12.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.